Your browser doesn't support javascript.
loading
Odronextamab, a human CD20×CD3 bispecific antibody in patients with CD20-positive B-cell malignancies (ELM-1): results from the relapsed or refractory non-Hodgkin lymphoma cohort in a single-arm, multicentre, phase 1 trial.
Bannerji, Rajat; Arnason, Jon E; Advani, Ranjana H; Brown, Jennifer R; Allan, John N; Ansell, Stephen M; Barnes, Jeffrey A; O'Brien, Susan M; Chávez, Julio C; Duell, Johannes; Rosenwald, Andreas; Crombie, Jennifer L; Ufkin, Melanie; Li, Jingjin; Zhu, Min; Ambati, Srikanth R; Chaudhry, Aafia; Lowy, Israel; Topp, Max S.
Affiliation
  • Bannerji R; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA. Electronic address: bannerra@cinj.rutgers.edu.
  • Arnason JE; Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Advani RH; Stanford University, Stanford, CA, USA.
  • Brown JR; Dana Farber Cancer Institute, Boston, MA, USA.
  • Allan JN; Weill Cornell Medicine, New York, NY, USA.
  • Ansell SM; Mayo Clinic, Rochester, MN, USA.
  • Barnes JA; Massachusetts General Hospital, Boston, MA, USA.
  • O'Brien SM; University of California, Irvine, CA, USA.
  • Chávez JC; Moffitt Cancer Center, Tampa, FL, USA.
  • Duell J; Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany.
  • Rosenwald A; Institute of Pathology, University of Würzburg, Würzburg, Germany.
  • Crombie JL; Dana Farber Cancer Institute, Boston, MA, USA.
  • Ufkin M; Regeneron Pharmaceuticals, Tarrytown, NY, USA.
  • Li J; Regeneron Pharmaceuticals, Tarrytown, NY, USA.
  • Zhu M; Regeneron Pharmaceuticals, Tarrytown, NY, USA.
  • Ambati SR; Regeneron Pharmaceuticals, Tarrytown, NY, USA.
  • Chaudhry A; Regeneron Pharmaceuticals, Tarrytown, NY, USA.
  • Lowy I; Regeneron Pharmaceuticals, Tarrytown, NY, USA.
  • Topp MS; Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany.
Lancet Haematol ; 9(5): e327-e339, 2022 May.
Article in En | MEDLINE | ID: mdl-35366963

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Lymphoma, Follicular / Lymphoma, Large B-Cell, Diffuse / Antibodies, Bispecific / Antineoplastic Agents Type of study: Clinical_trials / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Lancet Haematol Year: 2022 Document type: Article Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Lymphoma, Follicular / Lymphoma, Large B-Cell, Diffuse / Antibodies, Bispecific / Antineoplastic Agents Type of study: Clinical_trials / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Lancet Haematol Year: 2022 Document type: Article Country of publication: Reino Unido